Novartis

0 Drug industry loses in India – fight over ‘patents vs poor’ to continue

The Indian Supreme Court has rejected a drug patent application by the international pharmaceutical firm Novartis, an event that merited coverage by the New York Times, BBC and many other media – news which you might think is mostly a matter for the business page or drug industry insiders. In fact, the case may represent one of the most difficult dilemmas in global health. It is a fight that is far from over.

2 Novartis vs. India: Patents vs. the poor?

Flickr, Brooks Elliott One of the biggest, thorniest dilemmas in global health is coming to a head in India. (And the biggest player in this arena, the Bill & Melinda Gates Foundation, with a former top Novartis executive running the global health program, has no comment on it. More on…